title: Homocysteine-mediated PPARalpha,gamma DNA methylation and its potential pathogenic mechanism in monocytes.
abstract: Homocysteine (Hcy) is an independent risk factor for cardiovascular disease, but the molecular mechanisms causing atherosclerosis in monocytes remain poorly characterized. The objective of the present study was to investigate the effects of Hcy on DNA methylation of PPARalpha,gamma and the underlying mechanism of PPARalpha,gamma expression that was induced by Hcy in monocytes. About 50, 100, 200, and 500 microM Hcy were added to the monocytes cultured for 48 h. PPARalpha,gamma that acted as lipid sensors and bind with mM affinities to ligands of antiatherosclerosis were determined by real-time reverse transcription-polymerase chain reaction and Western blotting in monocytes. Here, we used a high-throughput quantitative methylation assay that utilizes fluorescence-based real-time polymerase chain reaction to determine the levels of the PPARalpha,gamma DNA methylation. S-adenosylmethionine (SAM) level and S-adenosylhomocysteine (SAH) level were detected by high performance liquid chromatography. Results indicated that the levels of PPARalpha,gamma promoter methylation in monocytes cultured with Hcy were increased in comparison with the control group, and the peak was in the 100 muM Hcy group, however, a dose-dependent increase with increasing Hcy was not seen. Hcy also decreased mRNA and protein levels of PPARalpha,gamma in monocytes. Further, with the addition of Hcy, the levels of SAH were elevated, the levels of SAM and the ratio of SAM/SAH were lower, and the activity of C-5MT-ase was increased. In conclusion, these results suggest that PPARalpha,gamma DNA methylation induced by Hcy may represent an important mechanism to explain atherosclerosis, which may become a therapeutic target for preventing atherosclerosis induced by Hcy.
authors.affiliation: Department of Pathophysiology, Ningxia Medical College, Yinchuan, Ningxia, PR China. jwcjyd@163.com
authors.forename: Jiang
authors.initials: J
authors.lastname: Yideng
authors.forename: Liu
authors.initials: L
authors.lastname: Zhihong
authors.forename: Xiong
authors.initials: X
authors.lastname: Jiantuan
authors.forename: Cao
authors.initials: C
authors.lastname: Jun
authors.forename: Li
authors.initials: L
authors.lastname: Guizhong
authors.forename: Wang
authors.initials: W
authors.lastname: Shuren
mesh_terms: D001483:Base Sequence; D002478:Cells, Cultured; D004248:DNA (Cytosine-5-)-Methyltransferases / Q000378:metabolism; D019175:DNA Methylation / Q000187:drug effects*; D004789:Enzyme Activation / Q000187:drug effects; D005487:Foam Cells / Q000378:metabolism / Q000473:pathology*; D006710:Homocysteine / Q000633:toxicity*; D006801:Humans; D008077:Lipoproteins, LDL / Q000494:pharmacology; D008262:Macrophage Activation / Q000187:drug effects; D008969:Molecular Sequence Data; D009000:Monocytes / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D047493:PPAR alpha / Q000235:genetics* / Q000378:metabolism; D047495:PPAR gamma / Q000235:genetics* / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D012435:S-Adenosylhomocysteine / Q000378:metabolism; D012436:S-Adenosylmethionine / Q000378:metabolism; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
chemical_list: D008077:Lipoproteins, LDL; D047493:PPAR alpha; D047495:PPAR gamma; D012333:RNA, Messenger; C099252:oxidized low density lipoprotein; D006710:Homocysteine; D012436:S-Adenosylmethionine; D012435:S-Adenosylhomocysteine; D004248:DNA (Cytosine-5-)-Methyltransferases; D013755:Tetradecanoylphorbol Acetate